{"transactions":[{"id":2660383,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T16:15:56.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 17, 2021."}],"balance_after":7800,"derivative":{"exercise_price":16.21,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-21-041979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919121041979/doc4.xml","form_type":"4"}},{"id":2660382,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T16:15:56.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 17, 2022."}],"balance_after":20050,"source":{"system":"sec-edgar","filing":"0001209191-21-041979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919121041979/doc4.xml","form_type":"4"}},{"id":2680502,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-04T22:37:44.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of 1) the Issuer's next annual stockholder meeting, or 2) June 2, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":4.07,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-038392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919121038392/doc4.xml","form_type":"4"}},{"id":3020577,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-09-29T20:39:27.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":3322,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3322},"source":{"system":"sec-edgar","filing":"0001209191-20-052338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120052338/doc4.xml","form_type":"4"}},{"id":3020576,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-29T20:39:27.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":3322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date."}],"balance_after":3322,"source":{"system":"sec-edgar","filing":"0001209191-20-052338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120052338/doc4.xml","form_type":"4"}},{"id":3021538,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-09-28T21:39:55.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/36th of the total shares on October 24, 2020 and on each monthly anniversary thereafter such that the option shall be fully vested on September 24, 2023, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":16,"expiration_date":"2030-09-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-052241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534133/000120919120052241/doc4.xml","form_type":"4"}},{"id":3097414,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-29T20:06:43.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 11, 2020."}],"balance_after":7800,"derivative":{"exercise_price":13.27,"expiration_date":"2020-06-11","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-20-039265","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919120039265/doc4.xml","form_type":"4"}},{"id":3097413,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-29T20:06:43.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 11, 2021."}],"balance_after":18300,"source":{"system":"sec-edgar","filing":"0001209191-20-039265","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919120039265/doc4.xml","form_type":"4"}},{"id":3152315,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-12T17:25:29.000Z","date":"2020-05-08","kind":"sale","acquired":false,"shares":5000,"price":15.27,"value":76350.0,"ownership":{"direct":true},"balance_after":16550,"source":{"system":"sec-edgar","filing":"0001209191-20-028588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919120028588/doc4.xml","form_type":"4"}},{"id":3513103,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-23T18:01:39.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of May 23, 2019."}],"balance_after":7800,"derivative":{"exercise_price":39.44,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-19-032411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919119032411/doc4.xml","form_type":"4"}},{"id":3513102,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-23T18:01:39.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on May 23, 2020."}],"balance_after":21550,"source":{"system":"sec-edgar","filing":"0001209191-19-032411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919119032411/doc4.xml","form_type":"4"}},{"id":3758542,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-19T16:54:19.000Z","date":"2018-11-16","kind":"purchase","acquired":true,"shares":2000,"price":41.7466,"value":83493.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.72 to $41.749, inclusive."}],"balance_after":19800,"source":{"system":"sec-edgar","filing":"0001209191-18-059222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919118059222/doc4.xml","form_type":"4"}},{"id":3882866,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-26T22:01:44.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":2632,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.11,"exercise_date":"2018-06-20","expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":2632},"source":{"system":"sec-edgar","filing":"0001209191-18-039537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118039537/doc4.xml","form_type":"4"}},{"id":3882865,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-26T22:01:44.000Z","date":"2018-06-25","kind":"exercise","acquired":false,"shares":8618,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.81,"exercise_date":"2018-06-20","expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":8618},"source":{"system":"sec-edgar","filing":"0001209191-18-039537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118039537/doc4.xml","form_type":"4"}},{"id":3882864,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-26T22:01:44.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":2632,"price":9.11,"value":23977.52,"ownership":{"direct":true},"balance_after":80145,"source":{"system":"sec-edgar","filing":"0001209191-18-039537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118039537/doc4.xml","form_type":"4"}},{"id":3882863,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-26T22:01:44.000Z","date":"2018-06-25","kind":"exercise","acquired":true,"shares":8618,"price":8.81,"value":75924.58,"ownership":{"direct":true},"balance_after":77513,"source":{"system":"sec-edgar","filing":"0001209191-18-039537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118039537/doc4.xml","form_type":"4"}},{"id":3885846,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-21T21:15:44.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2019."}],"balance_after":11250,"derivative":{"exercise_price":10.74,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001209191-18-038979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118038979/doc4.xml","form_type":"4"}},{"id":3899647,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T19:58:54.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 7, 2018."}],"balance_after":7800,"derivative":{"exercise_price":65.15,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-18-036809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919118036809/doc4.xml","form_type":"4"}},{"id":3899646,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T19:58:54.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 7, 2019."}],"balance_after":17800,"source":{"system":"sec-edgar","filing":"0001209191-18-036809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919118036809/doc4.xml","form_type":"4"}},{"id":3916787,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-25T16:01:42.000Z","date":"2018-05-25","kind":"purchase","acquired":true,"shares":1000,"price":49.45,"value":49450.0,"ownership":{"direct":true},"balance_after":16050,"source":{"system":"sec-edgar","filing":"0001209191-18-033483","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919118033483/doc4.xml","form_type":"4"}},{"id":3921744,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-22T18:04:08.000Z","date":"2018-05-21","kind":"purchase","acquired":true,"shares":1000,"price":50.245,"value":50245.0,"ownership":{"direct":true},"balance_after":15050,"source":{"system":"sec-edgar","filing":"0001209191-18-032407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919118032407/doc4.xml","form_type":"4"}},{"id":3932447,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-15T21:01:55.000Z","date":"2018-05-11","kind":"exercise","acquired":false,"shares":45454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.4,"expiration_date":"2023-06-16","underlying":"Common Stock","underlying_shares":45454},"source":{"system":"sec-edgar","filing":"0001209191-18-030253","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118030253/doc4.xml","form_type":"4"}},{"id":3932446,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-15T21:01:55.000Z","date":"2018-05-11","kind":"exercise","acquired":true,"shares":45454,"price":0.4,"value":18181.6,"ownership":{"direct":true},"balance_after":68895,"source":{"system":"sec-edgar","filing":"0001209191-18-030253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118030253/doc4.xml","form_type":"4"}},{"id":3983674,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-23T13:17:59.000Z","date":"2018-03-22","kind":"purchase","acquired":true,"shares":7500,"price":11.89,"value":89175.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $11.83  to $11.95, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":23441,"source":{"system":"sec-edgar","filing":"0001209191-18-021358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919118021358/doc4.xml","form_type":"4"}},{"id":4233610,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-08-15T21:40:57.000Z","date":"2017-08-11","kind":"purchase","acquired":true,"shares":5000,"price":7.08,"value":35400.0,"ownership":{"direct":true},"balance_after":15941,"source":{"system":"sec-edgar","filing":"0001209191-17-049039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919117049039/doc4.xml","form_type":"4"}},{"id":4263325,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-05T22:04:47.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":2632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 30, 2018."}],"balance_after":2632,"derivative":{"exercise_price":9.11,"expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":2632},"source":{"system":"sec-edgar","filing":"0001209191-17-043399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919117043399/doc4.xml","form_type":"4"}},{"id":4273220,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-23T20:36:20.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":8618,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2018."}],"balance_after":8618,"derivative":{"exercise_price":8.81,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":8618},"source":{"system":"sec-edgar","filing":"0001209191-17-041671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919117041671/doc4.xml","form_type":"4"}},{"id":4286757,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T16:09:18.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 8, 2017."}],"balance_after":10000,"derivative":{"exercise_price":52.85,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-038864","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919117038864/doc4.xml","form_type":"4"}},{"id":4286756,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T16:09:18.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 8, 2018."}],"balance_after":14050,"source":{"system":"sec-edgar","filing":"0001209191-17-038864","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919117038864/doc4.xml","form_type":"4"}},{"id":4315311,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-17T16:05:43.000Z","date":"2017-05-09","kind":"purchase","acquired":true,"shares":1000,"price":39.9,"value":39900.0,"ownership":{"direct":true},"balance_after":12900,"source":{"system":"sec-edgar","filing":"0001209191-17-033038","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919117033038/doc4.xml","form_type":"4"}},{"id":4340221,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-01T22:37:13.000Z","date":"2017-03-27","kind":"purchase","acquired":true,"shares":14064,"price":7.1,"value":99854.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Cagle Business Interests, Ltd. is the record holder of these securities.  The reporting person is the general partner of Cagle Business Interests, Ltd. and may be deemed to share voting and dispositive power over these securities. The reporting person disclaims beneficial ownership of these securities and this report is not an admission that the reporting person is a beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein."}],"balance_after":14064,"source":{"system":"sec-edgar","filing":"0001209191-17-029014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919117029014/doc4.xml","form_type":"4"}},{"id":4348512,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-20T16:55:49.000Z","date":"2017-04-19","kind":"purchase","acquired":true,"shares":1000,"price":41.8,"value":41800.0,"ownership":{"direct":true},"balance_after":11900,"source":{"system":"sec-edgar","filing":"0001209191-17-027736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919117027736/doc4.xml","form_type":"4"}},{"id":4348511,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-20T16:55:49.000Z","date":"2017-04-19","kind":"purchase","acquired":true,"shares":1000,"price":41.6,"value":41600.0,"ownership":{"direct":true},"balance_after":10900,"source":{"system":"sec-edgar","filing":"0001209191-17-027736","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1337553/000120919117027736/doc4.xml","form_type":"4"}},{"id":4377414,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":138050,"kind":"person","name":"Cagle Gerald D.","position":1,"cik":"0001589991","reported_name":"Cagle Gerald D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-20T21:23:04.000Z","date":"2017-03-16","kind":"purchase","acquired":true,"shares":5000,"price":6.84,"value":34200.0,"ownership":{"direct":true},"balance_after":10941,"source":{"system":"sec-edgar","filing":"0001209191-17-021777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1539029/000120919117021777/doc4.xml","form_type":"4"}}]}